| Therapeutic targeting of CDK12/CDK13 in triple-negative breast cancer V Quereda, S Bayle, F Vena, SM Frydman, A Monastyrskyi, WR Roush, ... Cancer cell 36 (5), 545-558. e7, 2019 | 218 | 2019 |
| Endochin Optimization: Structure−Activity and Structure−Property Relationship Studies of 3-Substituted 2-Methyl-4(1H)-quinolones with Antimalarial Activity RM Cross, A Monastyrskyi, TS Mutka, JN Burrows, DE Kyle, R Manetsch Journal of medicinal chemistry 53 (19), 7076-7094, 2010 | 141 | 2010 |
| The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells K Maharaj, JJ Powers, A Achille, M Mediavilla-Varela, W Gamal, ... Blood advances 4 (13), 3072-3084, 2020 | 63 | 2020 |
| Metal-Free Arylation of Ethyl Acetoacetate with Hypervalent Diaryliodonium Salts: An Immediate Access to Diverse 3-Aryl-4(1H)-Quinolones A Monastyrskyi, NK Namelikonda, R Manetsch The Journal of organic chemistry 80 (5), 2513-2520, 2015 | 62 | 2015 |
| Orally Bioavailable 6-Chloro-7-methoxy-4(1H)-quinolones Efficacious against Multiple Stages of Plasmodium RM Cross, DL Flanigan, A Monastyrskyi, AN LaCrue, FE Sáenz, ... Journal of Medicinal Chemistry 57 (21), 8860-8879, 2014 | 43 | 2014 |
| 4(1H)-Quinolones with Liver Stage Activity against Plasmodium berghei AN LaCrue, FE Sáenz, RM Cross, KO Udenze, A Monastyrskyi, S Stein, ... Antimicrobial agents and chemotherapy 57 (1), 417-424, 2013 | 43 | 2013 |
| Design and Synthesis of Orally Bioavailable Piperazine Substituted 4(1H)-Quinolones with Potent Antimalarial Activity: Structure–Activity and Structure–Property … R Neelarapu, JR Maignan, CL Lichorowic, A Monastyrskyi, TS Mutka, ... Journal of medicinal chemistry 61 (4), 1450-1473, 2018 | 35 | 2018 |
| Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer A Monastyrskyi, N Nilchan, V Quereda, Y Noguchi, C Ruiz, W Grant, ... Bioorganic & medicinal chemistry 26 (3), 590-602, 2018 | 34 | 2018 |
| 4 (1H)-pyridone and 4 (1H)-quinolone derivatives as antimalarials with erythrocytic, exoerythrocytic, and transmission blocking activities A Monastyrskyi, D E Kyle, R Manetsch Current topics in medicinal chemistry 14 (14), 1693-1705, 2014 | 30 | 2014 |
| The promise and current status of CDK12/13 inhibition for the treatment of cancer S Tadesse, DR Duckett, A Monastyrskyi Future Medicinal Chemistry 13 (2), 117-141, 2021 | 28 | 2021 |
| Resonance Ultrasonic Vibrations for in-line crack detection in silicon wafers and solar cells A Monastyrskyi, S Ostapenko, O Polupan, H Maeckel, M Vazquez 2008 33rd IEEE Photovoltaic Specialists Conference, 1-6, 2008 | 20 | 2008 |
| Transition-metal-free one-pot tandem synthesis of 4-quinolone and 4H-thiochromen-4-one derivatives through sequential nucleophilic addition–elimination–SNAr reaction D Wang, P Sun, P Jia, J Peng, Y Yue, C Chen Synthesis 49 (18), 4309-4320, 2017 | 18 | 2017 |
| Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitors A Monastyrskyi, S Bayle, V Quereda, W Grant, M Cameron, D Duckett, ... Bioorganic & medicinal chemistry letters 28 (3), 400-404, 2018 | 11 | 2018 |
| Aminoalkoxycarbonyloxymethyl ether prodrugs with a pH-triggered release mechanism: A case study improving the solubility, bioavailability, and efficacy of antimalarial 4 (1 H … A Monastyrskyi, F Brockmeyer, AN LaCrue, Y Zhao, SP Maher, ... Journal of medicinal chemistry 64 (10), 6581-6595, 2021 | 10 | 2021 |
| Targeting casein kinase 1 delta sensitizes pancreatic and bladder cancer cells to gemcitabine treatment by upregulating deoxycytidine kinase F Vena, S Bayle, A Nieto, V Quereda, M Aceti, SM Frydman, SS Sansil, ... Molecular cancer therapeutics 19 (8), 1623-1635, 2020 | 10 | 2020 |
| Compounds having antiparasitic or anti-infectious activity MK Riscoe, JX Kelly, RW Winter, DJ Hinrichs, MJ Smilkstein, A Nilsen, ... US Patent 8,598,354, 2013 | 10 | 2013 |
| Potassium tert-butoxide mediated arylation of 2-substituted malononitriles using diaryliodonium salts J Han, X Qian, B Xu, L Wang Synlett 28 (16), 2139-2142, 2017 | 8 | 2017 |
| Scalable Multigram Syntheses of Antimalarial 4 (1H)‐Quinolones ELQ‐300 and P4Q‐391 NK Namelikonda, A Monastyrskyi, R Manetsch European Journal of Organic Chemistry 2017 (23), 3328-3334, 2017 | 7 | 2017 |
| Chemical proteomics with novel fully functionalized fragments and stringent target prioritization identifies the glutathione-dependent isomerase GSTZ1 as a lung cancer target Y Liao, S Chin Chan, EA Welsh, B Fang, L Sun, E Schönbrunn, ... ACS Chemical Biology 18 (2), 251-264, 2023 | 5 | 2023 |
| Going beyond binary: rapid identification of protein–protein interaction modulators using a multifragment kinetic target-guided synthesis approach K Nacheva, SS Kulkarni, M Kassu, D Flanigan, A Monastyrskyi, ID Iyamu, ... Journal of Medicinal Chemistry 66 (7), 5196-5207, 2023 | 4 | 2023 |
